Get the Stockscreener App
6.28
51.69%
2.14
Pre-market:
6.20
-0.08
-1.27%
Optimizerx Corp stock is traded at $6.28, with a volume of 16.37M.
It is up +51.69% in the last 24 hours and up +12.34% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$4.14
Open:
$4.85
24h Volume:
16.37M
Relative Volume:
36.84
Market Cap:
$115.68M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-7.85
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+25.35%
1M Performance:
+12.34%
6M Performance:
-15.82%
1Y Performance:
-53.69%
1-Day Range:
$4.85
$6.74
1-Week Range:
$3.9914
$6.74
52-Week Range:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.28 | 115.68M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
233.46 | 37.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.01 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
64.30 | 12.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
95.78 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.50 | 7.84B | 640.44M | -743.28M | -206.93M | -11.29 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations - The Manila Times
OPTIMIZERx receives director nominations from Whetstone Capital Advisors -March 11, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx receives board nomination notice from Whetstone - Investing.com
OptimizeRx Faces Board Shakeup as Activist Investor Pushes for Change - StockTitan
OptimizeRx appoints Steve Silvestro as new CEO By Investing.com - Investing.com Canada
OptimizeRx appoints Steve Silvestro as new CEO - Investing.com India
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - The Manila Times
OPTIMIZERx appoints Stephen Silvestro as CEO -March 10, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx (OPRX) to Release Earnings on Wednesday - MarketBeat
OptimizeRx Corp. to Host Earnings Call - ACCESS Newswire
What Does OptimizeRx Corporation's (NASDAQ:OPRX) Share Price Indicate? - Yahoo Finance
Investor Network: OptimizeRx Corp to Host Earnings Call - ACCESS Newswire
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET - The Manila Times
OptimizeRx Corp. Announces Conference Call to Discuss Fiscal 2024 Financial Results on March 12, 2025 - Nasdaq
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March ... - The Bakersfield Californian
OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Head to Head Review: NextMart (OTCMKTS:NXMR) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles - Investing.com
SG Americas Securities LLC Acquires New Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Why Insider Buys at OptimizeRx Could Signal Undervalued Potential - Smartphone Magazine
One OptimizeRx Insider Raised Their Stake In The Previous Year - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Receives "Market Outperform" Rating from JMP Securities - MarketBeat
JPMorgan Chase & Co. Sells 104,750 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Where OptimizeRx Stands With AnalystsOptimizeRx (NASDAQ:OPRX) - Benzinga
Whetstone Capital Discloses 8.2% Stake in OptimizeRx, Urges Strategic Alternatives - Yahoo Finance
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.06 Consensus Target Price from Brokerages - Defense World
Chuck Royce's Strategic Acquisition of OptimizeRx Corp Shares - GuruFocus.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx (NASDAQ:OPRX) adds US$12m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Strong week for OptimizeRx (NASDAQ:OPRX) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Contrasting Ucommune International (NASDAQ:UK) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Jane Street Group LLC - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
OptimizeRx's SWOT analysis: digital health stock faces headwinds amid growth potential - Investing.com
RBC Capital Downgrades OptimizeRx (OPRX) - MSN
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):